Topic: genomics sequencing
An expanded understanding of the genetics behind breast cancer and blood pressure could improve treatments.
Machine learning identified mutations in 60 genes that raise the risk of abdominal aortic aneurysm (AAA).
Loxo is preparing for a November verdict from the FDA on larotrectinib as a treatment for solid tumors with NTRK fusions.
Merck paired up with Foundation Medicine to develop a pan-cancer diagnostic for Keytruda to measure microsatellite instability and other biomarkers.
Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.
The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.
Hannes Smárason chats with FierceBiotech about WuXi NextCODE's technology, products, investments and the road ahead.
WuXi NextCODE tapped Christina Waters, Ph.D., founder and CEO of a pediatric rare disease nonprofit, to lead its rare disease efforts.
Scientists believe they've discovered a novel gene that can be inhibited with antisense technology to treat cancer.
Centogene has raised $28 million to expand its presence in the U.S. and China.